Skip to main content
OMEROS CORP logo

OMEROS CORP — Investor Relations & Filings

Ticker · OMER ISIN · US6821431029 LEI · 549300CJWLXX2MXVVV71 US Manufacturing
Filings indexed 763 across all filing types
Latest filing 2021-05-10 Regulatory Filings
Country US United States of America
Listing US OMER

About OMEROS CORP

https://www.omeros.com/

Omeros Corporation is a biopharmaceutical company focused on discovering, developing, and commercializing small-molecule and protein therapeutics. The company leverages innovative science to build a diverse pipeline of first-in-class drug candidates designed to address challenging diseases and disorders with significant unmet medical needs. Omeros concentrates on developing therapeutics with novel mechanisms of action that target previously untapped receptors and enzymes, aiming to provide next-generation treatments for patients.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings
2021-05-10 English
DEF 14A
Proxy Solicitation & Information Statement
2021-04-30 English
Director's Dealing 2021
Director's Dealing
2021-04-09 English
424B5
Prospectus
2021-03-01 English
10-K
Annual Report FY 2020
2021-03-01 English
8-K
Regulatory Filings
2021-03-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.